VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K952. A total of 6 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $315,000 | -92.0% | 525,000 | -49.7% | 0.00% | -90.3% |
| Q1 2018 | $3,915,000 | +27864.3% | 1,043,600 | +406.8% | 0.03% | – |
| Q4 2017 | $14,000 | -97.4% | 205,900 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $535,000 | -78.6% | 205,900 | -58.8% | 0.01% | -72.2% |
| Q1 2016 | $2,500,000 | – | 500,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 247,300 | $54,938,000 | 0.77% |
| Timber Hill LLC | 176,800 | $39,276,000 | 0.18% |
| SABBY MANAGEMENT, LLC | 85 | $1,888,000 | 0.07% |
| Citadel Advisors | 225,300 | $50,050,000 | 0.04% |
| SIMPLEX TRADING, LLC | 1,411 | $320,000 | 0.03% |